Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
- Enrollment
- 608
- Started
- Mar 2014
- Completion
- Jun 2027
- Locations
- 654
- Countries
- 2
- Updated
- Jul 2026
Search thousands of peptide clinical trials from ClinicalTrials.gov. Follow the compound, sponsor, indication, phase, location, results and publication trail in one research index.
Query terminal
Search by peptide, drug, company, NCT ID or indication. Layer recruitment, phase, condition, country, results and publication filters without downloading the full registry snapshot.
2,643 matching studies
Last registry update first
Market intelligence
The charts use study start dates, phase labels, lead sponsors and geocoded registry locations from the same local snapshot as the search results. Counts may overlap when a study spans phases, compounds or condition groups.
Velocity
Study start year · indexed snapshot
Development
Therapeutic areas
Industry
Geography
Geography
5,179 geocoded sites · 355 clusters
Peptide coverage
Each molecule has its own evidence dashboard, trial timeline, status breakdown, study list and publication trail.
High-volume registry queries are capped at the 75 most recently updated matches in this snapshot. The registry match count is shown separately so indexed coverage stays explicit.
Provenance
Every study page links to its source record. PeptideStat stores a normalized snapshot so filters and pages remain fast, then records status, result and publication changes between syncs.
Clinical-trial registration does not establish safety, efficacy or regulatory approval. Always read the protocol, results and linked publications in context.